Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ambalal Sarabhai Enterprises has informed the exchange that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 26, 2022, to transact the following: To consider and approve the Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2022 and Any other matter as the Board of Directors of the Company may decide during the course of the meeting. Further, in continuation of its intimation dated March 31, 2022 and pursuant to Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of the Company is closed from April 1, 2022 to May 28, 2022.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |